Target intelligence / Profile preview

Ribonucleotide reductase subunit 1 (RRM1)

Target
RRM1
Molecular classification
Enzyme, Oxidoreductase
01

Overview

Ribonucleotide reductase subunit 1 (RRM1) is the large subunit of ribonucleotide reductase, a key enzyme that catalyzes the reduction of ribonucleoside diphosphates to deoxyribonucleoside diphosphates, providing the essential precursors for DNA synthesis and repair[1][4]. RRM1, together with the small subunit (RRM2 or RRM2B in humans), forms the active enzyme complex and is regulated allosterically to balance the relative concentrations of deoxyribonucleotides required for DNA replication and cell division[1]. Ribonucleotide reductase activity is vital for cell proliferation, and its inhibition forms the basis of several anti-cancer and antiviral therapies. Abnormal expression or dysregulation of RRM1 is associated with altered sensitivity to chemotherapeutics and with various malignancies, making it both a therapeutic target and a predictive biomarker[1][4].

Other names
RRM1Ribonucleotide reductase large subunitRibonucleoside-diphosphate reductase large chainRNR large subunit
02

Mechanism of action

Inhibition of deoxyribonucleotide synthesis (prevents DNA synthesis and repair by limiting the supply of deoxynucleotides)

03

Biological functions

DNA synthesisDNA repairCell proliferationCell cycle regulation
04

Disease associations

CancerOther (e.g., viral infections, as target for antivirals)
05

Safety considerations

MyelosuppressionAnemiaSecondary malignanciesPotential for increased toxicity when combined with DNA-damaging agents
06

Interacting drugs

Gemcitabine

4 more in the full profile.

07

Biomarkers

RRM1 protein expression (used as a marker for predicting response to nucleoside analog chemotherapy)

Beyond the preview

Go deeper on Ribonucleotide reductase subunit 1 (RRM1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribonucleotide reductase subunit 1 (RRM1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call